Navigation Links
DIA and National Pharmaceutical Council Will Host Two-Day Conference on Comparative Effectiveness Research
Date:2/28/2012

WASHINGTON, Feb. 28, 2012 /PRNewswire/ -- DIA and the National Pharmaceutical Council (NPC) will co-host the Comparative Effectiveness: A Real-World User's Guide Conference on March 14-15 at the Renaissance Washington Hotel in Washington, D.C. The conference will focus on the continued push for increased levels of evidence of comparative effectiveness research (CER) applied within health technology assessments, research planning and drug development.

Three distinguished CER researchers -- Bryan R. Luce, Senior Vice President, Science Policy, United BioSource Corp., Sean Tunis, Founder and Director, Center for Medical Technology Policy, and Brian Sweet, Executive Director, Healthcare Alliances, AstraZeneca -- will announce the first set of guiding principles developed for conducting CER studies. They also will discuss the practical application of the principles, and debate the effects the principles may have on various constituency groups, including patients, payers, and pharmaceutical industry manufacturers.

More than $1 billion dollars has been invested in comparative effectiveness research, and funding is only expected to grow in coming years. CER is designed to inform health care decisions by providing evidence on the effectiveness, benefits and harms of different treatment options. The evidence is generated from research studies that compare drugs, medical devices, tests, surgeries or ways to deliver health care. As CER becomes a standard by which patient access to new products and services is granted, the need to develop guiding principles to help yield desirable results is heightened.

The conference and sessions are timely as the complexities involved in comparative effectiveness research continue to demand principles and guidelines that can help govern and frame the entire CER enterprise. In addition, the recent creation of the Patient-Centered Outcomes Researc
'/>"/>

SOURCE DIA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference
2. Osseon® Announces International Distribution Agreement with Aesculap
3. NMEDA Introduces National Mobility Awareness Month for Seniors, Veterans and People with Disabilities
4. CVS Caremarks MinuteClinic to Deploy Allscripts EHR Nationally
5. SurgLine International, Inc. Update to Shareholders on Revenue Pipeline and Organizational Changes
6. National Coalition Holds Prescription Drug Take-back Day in Palm Springs Ahead of Pain Medicine Scientific Meeting
7. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
8. To Take a Glance Cutting Edge Medicine Equipment! The 28th International Medical & Hospital Equipment Show
9. National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012
10. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
11. Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and Eclampsia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Spanien, September 2, 2014 ... Das auf dem ESC-Kongress 2014 präsentierte ... Behandlung und Behandlungsergebnisse von schlaganfallgefährdeten Patienten ... Die Daten der ... Patienten, einer innovativen und unabhängigen Forschungsinitiative ...
(Date:9/2/2014)... September 2, 2014 , ... 2014 provide insight into treatment and outcomes of ... practice --   Data from nearly ... in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent ... strategies for atrial fibrillation (AF) patients remain sub-optimal ...
(Date:9/2/2014)... , Sept. 2, 2014 Particle Sciences, the ... its investment in development and manufacturing capabilities with the ... Karl Mueller , Particle Sciences, Associate Director Clinical Production, ... adding clean room square footage, equipment and staff across ... The company now has over 6000ft 2 of ...
Breaking Medicine Technology:Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
... , ... The Gamida Cell-Teva Joint Venture,(JV) announced today that the ... registration, Phase,III clinical trial of StemEx (called ExCell) and has recommended ... data analysis is,anticipated to take place during Q2 2010. StemEx is ...
... , Feb. 9 CareFusion Corp. (NYSE: ... from continuing operations for the three and six months ended ... during our second quarter and performed ahead of our expectations," said ... spending made modest improvements during the quarter and we continued to ...
Cached Medicine Technology:Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3CareFusion Reports Second Quarter Results 2CareFusion Reports Second Quarter Results 3CareFusion Reports Second Quarter Results 4CareFusion Reports Second Quarter Results 5CareFusion Reports Second Quarter Results 6CareFusion Reports Second Quarter Results 7CareFusion Reports Second Quarter Results 8CareFusion Reports Second Quarter Results 9CareFusion Reports Second Quarter Results 10CareFusion Reports Second Quarter Results 11CareFusion Reports Second Quarter Results 12CareFusion Reports Second Quarter Results 13CareFusion Reports Second Quarter Results 14CareFusion Reports Second Quarter Results 15CareFusion Reports Second Quarter Results 16CareFusion Reports Second Quarter Results 17CareFusion Reports Second Quarter Results 18
(Date:9/2/2014)... State University biochemists have discovered a family of proteins ... aureus , a pathogenic bacterium that can cause more ... Geisbrecht, professor of biochemistry and molecular biophysics, and Kasra ... , which is the cause of increasing common staph ... Proceedings of the National Academy of Sciences , or ...
(Date:9/2/2014)... have made it clear that a mother,s eating habits ... a profound impact on her offspring and their propensity ... now, the mechanisms behind this phenomenon were unclear. According ... of The FASEB Journal F , scientists ... a mother,s diet and an offspring,s risk of future ...
(Date:9/2/2014)... Many people believe that marijuana is not addictive, but ... people are able to obtain and consume cannabis legally ... are less likely to perceive it as addictive or ... General Hospital,s Center for Addiction Medicine, said in a ... use can have significant consequences, and we know that ...
(Date:9/2/2014)... Malvern, PA (PRWEB) September 02, 2014 ... healthcare communications and education, is proud to announce the ... and clinical resource center designed for healthcare professionals who ... website offers practitioners comprehensive access to:, , ... , Dedicated topic centers for diabetes, oncology, ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Healthcare professionals ... and most complete oncology guidelines available at the point ... and the National Comprehensive Cancer Network® ... other evidence and guidelines in the content available from ... , NCCN, a not-for-profit alliance of 25 of the ...
Breaking Medicine News(10 mins):Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4
... growth of cancer cells in lab study , THURSDAY, Nov. ... form of leukemia holds promise as a possible treatment for ... (Sprycel) is used to treat chronic myeloid leukemia. Researchers at ... drug limited the growth and invasive powers of ovarian cancer ...
... ... and his company, Nationwide Relocation Services, are enormous supporters of breast cancer ... lethal disease are growing by number, as both men and women are ... its power to assist in costumers, moves when coping with such difficult ...
... ... PDF conversion product line. PDF2Office® for iWork a new product to convert PDF to ... ... Recosoft Corporation the developer of the PDF2Office® family of products, PDF2ID® tool for InDesign®, ...
... ... are under even more pressure to perform during the swine flu ... large and small over the coming months. While some large businesses ... for their employees, many medium and smaller businesses are not protected. ...
... FREEHOLD, N.J., Nov. 11 Speedus Corp. (Nasdaq: SPDE ... Graham was appointed to the Company,s Board of Directors. , ... which he founded in 1988, and has been a General ... Crosshill Debt II, L.P. since 2004. Prior to these roles ...
... Forward thinking Mayor A.C. Wharton, sees Benefit in New ... Memphis Mayor, A.C. Wharton stands up for the outstanding ... hosted by University of Tennessee Health & Science Center on ... Madison in Room 305. The National Bipolar Foundation has been ...
Cached Medicine News:Health News:Leukemia Drug May Help Some Ovarian Cancer Patients 2Health News:Nationwide Relocation Services Support Breast Cancer Awareness 2Health News:Nationwide Relocation Services Support Breast Cancer Awareness 3Health News:PDF2Office for iWork -- New Utility to Convert PDF Files Directly to Native Keynote & Pages '08/'09 Formats Ships 2Health News:PDF2Office for iWork -- New Utility to Convert PDF Files Directly to Native Keynote & Pages '08/'09 Formats Ships 3Health News:How to Survive Recession and Swine Flu Outbreak in Your Employees 2Health News:Speedus Corp. Names Stephen X. Graham to Board of Directors 2Health News:Memphis Mayor Endorses National Bipolar Foundation 2
... PowerSuite holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
... VersaPulse PowerSuite holmium laser combines excellent ... precise, virtually bloodless procedures. It is ... and gall bladder stones of all ... surgical tool. Because its laser light ...
... perfecting mini-invasive endoscopic methods for ensuring extremely ... considerable social impact. The use of these ... and represents a valid backup in cutting ... family of Nd:YAG lasers is growing, developing ...
... hair removal for all skin ... Used for leg and facial ... Offers a large spot sizes ... fast treatment. An optional ...
Medicine Products: